Adaptive Biotechnologies Corp reports results for the quarter ended in December - Earnings Summary

Adaptive Biotechnologies

14/02/2023 22:02

* Adaptive Biotechnologies Corp  ADPT.OQ  reported a
quarterly
adjusted loss of 28 cents​​ per share for the quarter ended in
December. The mean expectation of ten analysts for the quarter
was for a loss of 35 cents per share.
    * Revenue rose 45.5% to $55.20 million from a year ago;
analysts
expected $54.71 million. 
    * Adaptive Biotechnologies Corp's reported EPS for the
quarter was
a loss of 28 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Adaptive Biotechnologies Corp shares had risen by 13.7%
this
quarter.
    * The company reported a quarterly loss of $40.13 million.
    * Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $13.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
14 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.35          -0.28          Beat
 Sep. 30 2022      -0.38          -0.32          Beat
 Jun. 30 2022      -0.43          -0.37          Beat
 Mar. 31 2022      -0.46          -0.44          Beat